HainesAEpsteinPRMcMichaelAJ, On behalf of an international panel: Global health watch: Monitoring impacts of environmental changeLancet1993, 342:1464–1469.
2.
StaessenJARoelsHLauwerysRRAmeryA: Low-level lead exposure and blood pressureJ Hum Hypertens1995, 9:303–328.
3.
The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: Final report of the Pooling ProjectJ Chron Dis1978, 31:201–306.
4.
KanneiWB: The role of blood pressure in cardiovascular morbidity and mortalityProg Cardiovasc Dis1974, 17:5–24.
5.
AnnestJLPirkleJLMakucDNeeseJWBayseDDKovarMG: Chronological trend in blood lead levels between 1976 and 1980N Engl J Med1983, 308:1373–1377.
6.
PirkleJLSchwartzJLandisJRHarlanWR: The relationship between blood lead levels and blood pressure and its cardiovascular complicationsAm J Epidemiol1985, 121:246–258.
7.
CoateDFowlesR: Is there statistical evidence for a blood lead-blood pressure relationship?J Health Econ1989, 8:173–184.
8.
GartsidePS: The relationship of blood lead levels and blood pressure in NHANES II: Additional calculationsEnviron Health Perspect1988, 78:31–34.
9.
SharpDSBeckerCESmithAH: Chronic low-level lead exposure. Its role in the pathogenesis of hypertensionMed Toxicol1987, 2:210–232.
10.
StadelBV: Oral contraceptives and cardiovascular disease [second of two parts]N Engl J Med1981, 305:672–677.
11.
StampferMJWillettWCColditzGASpeizerFEHennekensCH: Prospective study of past use of oral contraceptive agents and risk of cardiovascular diseasesN Engl J Med1988, 319:427–433.
12.
MacMahonSPetoRCutlerJCollinsRSorliePNeatonJ: Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution biasLancet1990, 335:765–774.
13.
CollinsRPetoRMacMahonSHebertPFiebachNHEberleinKA: Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological contextLancet1990, 335:827–838.
14.
USA Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry: Toxicological Profile for Arsenic (TP-92/02). Atlanta, GA: USA Department of Health and Human Services; 1992.
15.
BuchetJPStaessenJRoelsHLauwerysRFagardR: Geographical and temporal differences in the urinary excretion of inorganic arsenic: A Belgian population study. Occup Environ Med1996 (in press).
